SCHEMBL28283532

SCHEMBL28283532

O=C(O)c1ccc2[nH]c(CN3CCCCC3C(F)(F)F)cc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.37
MLLT1 Q03111 2/20 0.37
JAK2 O60674 1/20 0.36
ROCK2 O75116 1/20 0.36
PRKD3 O94806 1/20 0.36
PRKCG P05129 1/20 0.36
PHKG2 P15735 1/20 0.36
RPS6KB1 P23443 1/20 0.36
MARK3 P27448 1/20 0.36
PRKCI P41743 1/20 0.36
CLK2 P49760 1/20 0.36
IRAK1 P51617 1/20 0.36
RPS6KA3 P51812 1/20 0.36
PRKCD Q05655 1/20 0.36
MAP4K2 Q12851 1/20 0.36
STK3 Q13188 1/20 0.36
CAMK2B Q13554 1/20 0.36
CAMK2G Q13555 1/20 0.36
CAMK2D Q13557 1/20 0.36
PKN2 Q16513 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29654096 0.86 MMP2 (0.43) HRH3JAK2ROCK2PRKD3PRKCG
SCHEMBL28797800 0.86 MMP2 (0.43) HRH3JAK2ROCK2PRKD3PRKCG
SCHEMBL19360618 0.82 IDO1 (0.39) HRH3JAK2ROCK2PRKD3PRKCG
SCHEMBL19360619 0.75 L3MBTL1 (0.40) HRH3IRAK1IRAK4GRM2HSD17B10
SCHEMBL8181089 0.71 HRH3 (0.48) HRH3LMNANPSR1KDM4EALDH1A1
SCHEMBL28283531 0.71 PTGER4 (0.42) CFB
SCHEMBL14972596 0.68 CYP1A2 (0.54) HRH3SSTR3MAPTLMNANPSR1
SCHEMBL29746437 0.68 KMT2A (0.51) HRH3SSTR3MAPTRAB9AKDM4E
SCHEMBL20570792 0.68 HRH3 (0.52) HRH3LMNANPSR1KDM4EALDH1A1
SCHEMBL30457877 0.68 HRH3 (0.52) HRH3LMNANPSR1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109485595-A Indole carboxamides analog derivative, preparation method and its application in medicine that hydrophilic radical replaces 江苏恒瑞医药股份有限公司 2019-03-19 CN disclosed